Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban
- 1 May 2003
- journal article
- case report
- Published by Elsevier in Thrombosis Research
- Vol. 110 (2-3) , 73-82
- https://doi.org/10.1016/s0049-3848(03)00336-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic PatientsArchives of internal medicine (1960), 2003
- Argatroban Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaArchives of internal medicine (1960), 2003
- Heparin‐induced thrombocytopenia: pathogenesis and managementBritish Journal of Haematology, 2003
- The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort studyBlood, 2003
- Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopeniaBlood, 2003
- Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 2002
- Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- A 14-year study of heparin-induced thrombocytopeniaThe American Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995